 LEXINGTON, Mass., Oct. 05, 2022 GLOBE NEWSWIRE -- Agenus Inc. NASDAQ: AGEN, an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced the Company will present new data on its growing portfolio of clinical-stage immuno-oncology programs at the Society for Immunotherapy of Cancer SITC 37th Annual Meeting, to be held November 8-12 in Boston, MA and virtually. 